Hypoglycemic and hypolipidemic effect and antioxidant activity of chronic epigallocatechin-gallate in streptozotocin-diabetic rats Mehrdad Roghani, Tourandokht Baluchnejadmojarad Pathophysiology Volume 17, Issue 1, Pages 55-59 (February 2010) DOI: 10.1016/j.pathophys.2009.07.004 Copyright © 2009 Elsevier Ireland Ltd Terms and Conditions
Fig. 1 Body weights and serum glucose, cholesterol, triglyceride, HDL- and LDL-cholesterol concentrations in controls and streptozotocin rats without or with epigallocathecin-gallate treatment (means±SEM). *p<0.05, **p<0.01, ***p<0.005, ****p<0.0001 (as compared to week 0 in the same group); #p<0.05, ###p<0.005 (as compared to diabetic in the same week). Pathophysiology 2010 17, 55-59DOI: (10.1016/j.pathophys.2009.07.004) Copyright © 2009 Elsevier Ireland Ltd Terms and Conditions